Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Basu, Bristi"'
Autor:
Balakrishnan, Anita, Barmpounakis, Petros, Demiris, Nikolaos, Jah, Asif, Spiers, Harry VM, Talukder, Shibojit, Martin, Jack L, Gibbs, Paul, Harper, Simon JF, Huguet, Emmanuel L, Kosmoliaptsis, Vasilis, Liau, Siong S, Praseedom, Raaj K, Basu, Bristi, de Aretxabala, Xavier, Lendoire, Javier, Maithel, Shishir, Branes, Alejandro, Andersson, Bodil, Serrablo, Alejandro, Adsay, Volkan, OMEGA Study Investigators
BACKGROUND: Gallbladder cancer (GBC) is rare but aggressive. The extent of surgical intervention for different GBC stages is non-uniform, ranging from cholecystectomy alone to extended resections including major hepatectomy, resection of adjacent org
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f77cda856488fdcd1f2ecceaed2dd161
Autor:
Ruth Riisnaes, Christina Guo, Priya Sriskandarajah, Maxime Chénard-Poirier, Jenny King, Samuel John Harris, Yuji Ishikawa, Emma Hall, Juanita Lopez, Anna Minchom, Nina Tunariu, Johann S. de Bono, Wen Xu, Suzanne Carreira, Anastasia Constantinidou, Alison Turner, Kiyohiko Nakai, Udai Banerji, Bristi Basu, Mariana Scaranti, Desamparados Roda, Laura Finneran, Irene Moreno Candilejo, Maria de Miguel, Mona Parmar, Martin Kaiser
Publikováno v:
The Lancet. Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Background CH5126766 (also known as VS-6766, and previously named R05126766), a novel MEK-pan-RAF inhibitor, has shown antitumour activity across various solid tumours; however, its initial development was limited by toxicity. We aimed to investigate
The process of anti-cancer drug development is complex, with high attrition rates. Factors that may optimise this process include well-constructed and relevant pre-clinical testing and use of biomarkers for patient selection. However, the design of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727fba4bdb49706abb0d6de641297970
https://www.repository.cam.ac.uk/handle/1810/305652
https://www.repository.cam.ac.uk/handle/1810/305652
Autor:
Silvia C Mendonca, Katie Mills, William Hamilton, John Lancaster, Greg Rubin, Jon Emery, Fiona M Walter, Nick Carroll, Sue Ballard, Bristi Basu, Gary A. Abel
Publikováno v:
The lancet gastroenterology and hepatology, 2016, Vol.1(4), pp.298-306 [Peer Reviewed Journal]
BACKGROUND: Pancreatic cancer is the tenth most common cancer in the UK; however, outcomes are poor, in part due to late diagnosis. We aimed to identify symptoms and other clinical and sociodemographic factors associated with pancreatic cancer diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43302bd848ea66c5534f0da2d890d881